UnknownNot Applicable

Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization.

China66 participantsStarted 2023-01-01

Plain-language summary

The purpose of this study is to determine whether a novel subset of neutrophils is correlated with corneal neovascularization in the patients suffered from ocular chemical injury.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Those who are diagnosed ocular diseases except for chemical ocular injury, such as uveitis, retinopathy.
✕. Those who are diagnosed allergic disease, autoimmune diseases or hematological diseases, infectious disease, such as eczema, systemic lupus erythematosus (SLE), agranulocytosis and viral hepatitis.
✕. Those who took immunosuppressive treatments in the past 3 months.
✕. Pregnant or nursing women.
✕. Those who have serious heart, lung, liver or kidney diseases.
✕. Those who have serious systemic diseases.
✕. Those who performed ocular surgery (including cataract surgery) in recent three months.
✕. Those who have been enrolled in other interventional clinical studies at the same time.

What they're measuring

Changes of angiogenic neutrophils ratio

Timeframe: Inclusion (Day1) and 1 week

Trial details

NCT IDNCT05659940

SponsorZhongshan Ophthalmic Center, Sun Yat-sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-30

Contact for this trial

Ziqi Yang

8618826227484 yangzq6@mail2.sysu.edu.cn

View on ClinicalTrials.gov More Corneal Neovascularization trials